De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)...

圣物

题名

De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)–Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor–Positive Phase II Randomized Trial—Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET

链接

http://ascopubs.org/doi/pdf/10.1200/JCO.2016.71.9815

pnas2009

链接: https://pan.baidu.com/s/1RKS3LoUNarcO-AkdWpyLqw 密码: bi6u